Company / Operating Margin
Foghorn Therapeutics Inc. Operating Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-454.3%
FY2025
5-year range
-15937.4% / -315.9%
FY2021-FY2025
Trend
-43.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -609.2% to -454.3% over the past 2 years.
Based on SEC 10-K filings.
-454.3% in FY2025 with a 5-year CAGR of +11425.7%.
Improved from -609.2% to -454.3% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +7182.8pp
- 5-Year Change
- +11425.7pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin decreased 43.8% year-over-year.
- Peak operating margin was recorded in FY2024.
- Lowest operating margin in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -454.3% | -43.8% |
| FY2024 | -315.9% | +48.1% |
| FY2023 | -609.2% | +92.0% |
| FY2022 | -7637.1% | +52.1% |
| FY2021 | -15937.4% | -34.2% |
| FY2020 | -11880.0% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026